Mercosur bloc moves to tighten blood products quality and safety
This article was originally published in Clinica
Executive Summary
South America’s Mercosur trading bloc has been discussing technical and regulatory issues related to blood products. Brazil’s foreign affairs ministry and healthcare products regulatory agency Anvisa hosted a week of workshops in Campinas, São Paulo. The information-sharing event, which ended yesterday, was attended by teams of representatives from Argentina, Brazil, Paraguay, Uruguay and Venezuela. Its main aim was to “promote improvements in quality- and safety-assurance in this area, through tighter regulation”, according to Anvisa. The main subjects on the agenda were good manufacturing practice (GMP), national regulatory frameworks and the harmonisation of regulations across the bloc.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.